Randomised Trial in Waldenstrom's Macroglobulinaemia
NCT01592981
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Waldenstrom's Macroglobulinaemia
Interventions
DRUG:
Bortezomib
DRUG:
Cyclophosphamide
BIOLOGICAL:
Rituximab
DRUG:
Fludarabine
Sponsor
University College, London